Learn About Tempus AI's AI Products
Create a free account to access in-depth lessons on each tool and model.
Start Learning Free📋About Tempus AI
Updated June 15, 2026Tempus AI (NASDAQ: TEM) is a clinical AI and precision medicine company that uses the largest multimodal clinical dataset in the industry — 40+ million records and 1.1 billion healthcare records — to help oncologists select the most effective targeted therapies. Founded by Eric Lefkofsky, Tempus combines genomic testing, AI software, and data licensing with $1.27 billion in 2025 revenue.
🛠️Products & Tools (1)
Clinical AI platform analyzing genomic and molecular data to help oncologists select the most effective targeted therapies for individual cancer patients.
